Project Grant R21AG095654
- Federal Project Grant Award Summary New York University received a $422,297 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded February 15, 2026, with completion targeted for January 31, 2028. The award supports research investigating the mechanisms by which frontotemporal dementia (FTD)-associated tau mutations disrupt protein synthesis in human neurons. The research deliverables include: (1) determination of how FTD-associated heterozygous tau...
- Federal Project Grant Award Summary The University of Illinois received a $1,592,854 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective June 1, 2025, through May 31, 2027. This award funds research investigating tau protein conformation in tauopathies, including Alzheimer's disease and related dementias such as progressive supranuclear palsy, cortical basal degeneration, and chronic traumatic encephalopathy. The research centers on...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Ohio University a Project Grant of $567,256 under the Aging Research program (CFDA 93.866) effective February 1, 2026, through January 31, 2029. The award supports research to elucidate the mechanisms of activity-dependent tau protein release from neurons, a process implicated in Alzheimer's disease (AD) pathogenesis and tau propagation between connected neurons. The research employs a Drosophila model and human neural...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $507,214 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded February 15, 2026, with a completion date of January 31, 2028. This exploratory/developmental research initiative investigates the role of long-noncoding RNA SLAMR (SLAMR lncRNA) in Alzheimer's disease pathogenesis. The research deliverables include systematic functional experiments assessing...
- Federal Project Grant Award Summary The National Institute on Aging awarded $433,125 to the University of Texas Health Science Center at San Antonio under the Aging Research program (CFDA 93.866) on September 15, 2025, with a completion date of August 31, 2027. This exploratory/developmental grant funds research investigating whether extracellular tau protein modulates neurogenesis through the low-density lipoprotein receptor related protein 1 (LRP1) in adult-born granule neurons. The project...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $2.33 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 1, 2025, through August 31, 2029. The award funds research evaluating neuroimmune mechanisms and therapeutic targeting potential of the luteinizing hormone/chorionic gonadotropin (LH/CG) receptor in menopausal and Alzheimer's disease-affected brains....
- Federal Project Grant Award Summary The National Institute on Aging awarded a Project Grant of $681,908 (Award Date: February 15, 2026; Completion Date: November 30, 2030) under the Aging Research program (CFDA 93.866) to The Regents of the University of California, San Francisco to support research on "Mechanisms of Protective UFM1-Dependent IRE1 Signaling in Tauopathies." The research will investigate molecular mechanisms linking the ufmylation pathway to tau protein homeostasis...
- Federal Project Grant Summary The National Institute on Aging (NIA) awarded $6.67 million to the University of Illinois under the Aging Research program (CFDA 93.866) for a four-year project (September 1, 2025 through August 31, 2029) focused on developing small molecule ligands to target pathological tau signaling in Alzheimer's disease and related dementias. The project addresses a critical gap in tau-targeted therapeutics by identifying and optimizing small molecule inhibitors that block...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of South Florida $3.297 million under the Aging Research program (CFDA 93.866) for a four-year project period (September 1, 2025 – August 31, 2029) to develop novel peptidomimetic biomaterials that inhibit amyloid-beta (Aβ42) aggregation in Alzheimer's disease. The research deliverables include the rational design and characterization of structurally related analogues to a lead compound that stabilizes Aβ...
- Federal Project Grant Award Summary New York University School of Medicine received a $390,906 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded July 15, 2025, with completion targeted for March 31, 2030. This research project delivers comprehensive scientific investigation into the selective vulnerability of basal forebrain cholinergic neurons (BFCNs) to tau pathology in Alzheimer's disease. The deliverables encompass three...
The University of Florida's Division of Sponsored Research received a $422,125 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) for the period of June 1, 2026, through May 31, 2028. The award funds research to investigate the impact of pathological tau protein on RNA and translation mechanisms in Progressive Supranuclear Palsy (PSP) and other tauopathies. The research deliverables include identification of RNA transcripts that bind to tau in primary tauopathies through analysis of human brain tissues, in vitro models, and in vivo mouse neural tissue models; characterization of newly translated proteins in the presence of pathological tau; and elucidation of the tau-mediated mechanism of translation dysfunction that impairs protein synthesis critical for memory function. The project addresses a significant gap in understanding how tau abnormalities contribute to neurodegeneration in diseases affecting nearly 50 million people worldwide. Deliverables are organized around two primary research aims supported by preliminary data demonstrating associations between tau and ribosome complexes and impaired protein synthesis networks in disease. The research outputs are designed to identify potential therapeutic targets for tauopathies through rigorous experimental methodology, controlled validation experiments, and statistical analysis. Findings from this award are expected to advance understanding of tau pathogenesis mechanisms and inform the development of targeted interventions for memory impairment associated with neurodegenerative disease.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $422.1k | 5/25/26 |